| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P23-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P23-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
1996-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8713cdf543a26d0320c24f31dbd8204b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_630c8fe63992305175c6855cf50c60a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d976eb42dd2045b7c2e21bc695e118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12d4ab147a0f6fe74da0a22e342d7108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb4a3ce1b4d6aa3f1bc632129454f4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41558596c79eb34d280e3069056ac2be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c579e3f7e57f5f946bf78881313403f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6e2910a9813b0c820e5d570aeda359e |
| publicationDate |
2007-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1336409-B1 |
| titleOfInvention |
Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| abstract |
Disclosed is the use of an omega-conopeptide in the manufacture of a medicament for inhibiting progression of neuropathic pain disorders. |
| priorityDate |
1995-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |